FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Coming soon

Pre-Clinical Models of Infectious Diseases

Pre-solicitation Notice Information Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading…

Notice typePresolicitation: Heads-up: the agency plans to post a bid soon. Get ready now.
Who's buyingNational Institutes of Health Niaid, National Institutes of Health
WhereWork location not listed. The buying office is in Bethesda, Maryland.
DeadlineMon, Dec 7, 2026 at 3:00 PM EST (44 days left)
Who can bidOpen to any business (no set-aside listed)
IndustryNAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology))
Solicitation #75N93027R00003
PostedMon, Oct 19, 2026
ContactIgnacio Reyes, Contracting Officer, [email protected]

Open the official posting

From the notice

Pre-solicitation Notice Information Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Microbiology and Infectious Diseases has a requirement to provide and develop animal models in order to advance our understanding of infectious diseases as well as advance the development of therapeutics and vaccines for infectious diseases. Description The National Institute of Allergy and Infectious Diseases (NIAID) supports and facilitates research that focuses on understanding, treating and, ultimately, preventing infectious, immunologic, and allergenic diseases. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports and facilitates research to understand, control and prevent human disease caused by infectious agents. Basic, applied and translational research to develop and assess therapeutics, vaccines, and diagnostics is supported through research grants, cooperative agreements, and contracts. In turn, DMID further supports and facilitates research ongoing under these funding mechanisms and through other programs via an array of preclinical and clinical resources and services to

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.